In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
We are very excited to launch our new website! Please take a few moments to click around and explore...